Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Lechleider

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|January 15, 2000
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domainM P de Caestecker, T Yahata, D Wang, et al.
The Journal of Biological Chemistry|March 30, 2001
Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperoneJ U Wurthner, D B Frank, A Felici, et al.
Genes & Development|July 11, 2000
A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transductionR H Kim, D Wang, M Tsang, et al.
The Journal of Biological Chemistry|March 30, 2001
Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinasesW T Parks, D B Frank, C Huff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsY J Bang, G Giaccone, S A Im, et al.
Nature Cell Biology|January 9, 2001
A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motifS Larisch, Y Yi, R Lotan, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|January 15, 2000
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domainM P de Caestecker, T Yahata, D Wang, et al.
The Journal of Biological Chemistry|March 30, 2001
Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperoneJ U Wurthner, D B Frank, A Felici, et al.
Genes & Development|July 11, 2000
A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transductionR H Kim, D Wang, M Tsang, et al.
The Journal of Biological Chemistry|March 30, 2001
Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinasesW T Parks, D B Frank, C Huff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsY J Bang, G Giaccone, S A Im, et al.
Nature Cell Biology|January 9, 2001
A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motifS Larisch, Y Yi, R Lotan, et al.
Pageof 3